The role of fatty acids in the treatment of ADHD

Neuropharmacology

Volumn 57, Issue 7-8, 2009, Pages 636-639

  Chalon, Sylvie ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

ADHD; Docosahexaenoic acid; n 3 polyunsaturated fatty acid

Indexed keywords

ALPHA TOCOPHEROL; ARACHIDONIC ACID; ASCORBIC ACID; CENTRAL STIMULANT AGENT; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FATTY ACID DERIVATIVE; FISH OIL; GAMMA LINOLENIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LONG CHAIN FATTY ACID; MINERAL OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PLACEBO; POLYUNSATURATED FATTY ACID; THYME OIL;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET SUPPLEMENTATION; DIETARY INTAKE; DOPAMINERGIC SYSTEM; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FAT INTAKE; FATTY ACID METABOLISM; HUMAN; NEUROPSYCHOLOGICAL TEST; NONHUMAN; NUTRITIONAL DEFICIENCY; NUTRITIONAL HEALTH; NUTRITIONAL STATUS; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; HUMANS;

EID: 70350218840     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.08.012     Document Type: Review

References (34)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth ed. (2000), American Psychiatric Association, Arlington, VA text revision
2. Antalis C.J., Stevens L.J., Campbell M., Pazdro R., Ericson K., and Burgess J.R. Omega-3 fatty acid status in attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 299-308
3. Barkley R.A. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol. Bull. 121 (1997) 65-94
4. Bourre J.-M., Pascal G., Durand G., Masson M., Dumont O., and Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J. Neurochem. 43 (1984) 342-348
5. Bourre J.-M., Francois M., Youyou A., Dumont O., Piciotti M., Pascal G., and Durand G. The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119 (1989) 1880-1892
6. Brookes K.J., Chen W., Xu X., Taylor E., and Asherson P. Association of fatty acid desaturase genes with attention-deficit/hyperactivity disorder. Biol. Psychiatry 60 (2006) 1053-1061
7. Burgess J.R., Stevens L., Zhang W., and Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 71 suppl (2000) 327S-330S
8. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot. Essent. Fatty Acids 75 (2006) 259-269
9. Colquhoun I., and Bunday S. A lack of essential fatty acid as a possible cause of hyperactivity in children. Med. Hypotheses 7 (1981) 673-679
10. Curatolo P., Paloscia C., D'Agati E., Moavero R., and Pasini A. The neurobiology of attention deficit/hyperactivity disorder. Eur. J. Paediatr. Neurol. 13 (2009) 299-304
11. Hirayama S., Hamazaki T., and Terasawa K. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study. Eur. J. Clin. Nutr. 58 (2004) 467-473
12. Johnson M., Ostlund S., Fransson G., Kadesjö B., and Gillberg C. Omega-3/Omega-6 fatty acids for attention deficit hyperactivity disorder. J. Attention Disord (2009) 10.1177/1087054708316261
13. Joshi K., Lad S., Kale M., Patwardhan B., Mahadik S.P., Patni B., Chaudhary A., Bhave S., and Pandit A. Supplementation with flax oil and vitamin C improves the outcome of attention deficit hyperactivity disorder (ADHD). Prostaglandins Leukot. Essent. Fatty Acids 74 (2006) 17-21
14. Kodas E., Vancassel S., Lejeune B., Guilloteau D., and Chalon S. Reversibility of n-3 fatty acid deficiency-induced changes in dopaminergic neurotransmission in rats: critical role of developmental stage. J. Lipid Res. 43 (2002) 1209-1219
15. Kodas E., Galineau L., Bodard S., Vancassel S., Guilloteau, Besnard J.-C., and Chalon S. Serotoninergic neurotransmission is affected by n-3 polyunsaturated fatty acids in the rat. J. Neurochem. 89 (2004) 695-702
16. McDonagh M.S. Drug Class Review on Pharmacologic Treatments for ADHD. Available at: (2007), Oregon Health & Science University, Portland, OR. http://www.ncbi.nlm.nih.gov/books/bookres.fcgi/adhd/pdfadhd.pdf (2007) (accessed16.10.08)
17. Mitchell E.A., Aman M.G., Turbott S.H., and Manku M. Clinical characteristics and serum essential fatty acid levels in hyperactive children. Clin. Pediatr. 26 (1987) 406-411
18. Raz R., Carasso R.L., and Yehuda S. The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study. J. Child. Adolesc. Psychopharmacol. 19 (2009) 167-177
19. Raz R., and Gabis L. Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review. Dev. Med. Child Neurol. 51 (2009) 580-592
20. Richardson A.J., and Puri B.K. A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 26 (2002) 233-239
21. Richardson A.J., and Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics 115 (2005) 1360-1366
22. Salem N., Wegher B., Mena P., and Uauy R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc. Natl. Acad. Sci. U S A 93 (1996) 49-54
23. Sinn N., and Bryan J. Effects of supplementation with polyunsaturated fatty acids and micronutrients on ADHA-related problems with attention and behavior. J. Dev. Behav. Pediatr. 28 (2007) 82-91
24. Spahis S., Vanasse M., Bélanger S.A., Ghadirian P., Grenier E., and Levy E. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients witj attention-deficit/hyperactivity disorder. Prostaglandins Leukot. Essent. Fatty Acids 79 (2008) 47-53
25. Sprecher H., Luthria D.L., Mohammed B.S., and Baykousheva S.P. Reevaluation of the pathways for the biosynthesis of polyunsaturated fatty acids. J. Lipid Res. 36 (1995) 2471-2477
26. Sorgi P.J., Hallowell E.M., Hutchins H.L., and Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr. J. 6 (2007) 16
27. Stevens L.J., Zentall S.S., Deck J.L., Abate M.L., Watkins B.A., Lipp S.R., and Burgess J.R. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 62 (1995) 761-768
28. Stevens L.J., Zentall S.S., Abate M.L., Kuczek T., and Burgess J.R. Omega-3 fatty acids in boys with behavior, learning, and health problems. Physiol. Behav. 59 (1996) 915-920
29. Stevens L.J., Zhan W., Peck L., Kuczek T., Grevstad N., Mahon A., Zentall S.S., Arnold L.E., and Burgess J.R. EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviours. Lipids 38 (2003) 1007-1021
30. Vaisman N., Kaysar N., Zaruk-Adasha Y., Pelled D., Brichon G., Zwingelstein G., and Bodennec J. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am. J. Clin. Nutr. 87 (2008) 1170-1180
31. Voigt R.G., Llorente A.M., Jensen C.L., Fraley J.K., Berretta M.C., and Heird W.C. A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder. J. Pediatr. 139 (2001) 189-196
32. Wainwright P.E. Essential Fatty Acid and Behavior. In: Yehuda S., and Mostofski D.I. (Eds). Handbook of Essential Fatty Acid Biology (1997), Humana Press, Totowa, New Jersey 299-341
33. Yamamoto N., Hashimoto A., Takemoto Y., Okuyama H., Nomura M., Kitajima R., Togashi T., and Tamai Y. Effects of the dietary alpha-linolenate/linoleate balance on lipid compositions and learning ability of rats. II. Discrimination process, extinction process, and glycolipid compositions. J. Lipid Res. 29 (1988) 1013-1021
34. Yehuda S., Rabinovitz S., and Mostofsky D.I. Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 56 (1999) 565-570